Deucravacitinib in Moderate to Severe Plaque Psoriasis: Comorbidities and Use of Prior and Concomitant Medication in Patients Enrolled in the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s428, 2024. DOI: 10.25251/skin.8.supp.428. Disponível em: https://skin.dermsquared.com/skin/article/view/3105. Acesso em: 19 may. 2025.